Featured products

You can also try the following methods, and our professionals will serve you Customized Consultation

Cat. No.	Product Name	Field of Application
DC10102	GSK189254A Featured	GSK189254A (GSK189254) is a novel, potent and selective histamine H3 receptor antagonist with pKi values of 9.59-9.90 and 8.51-9.17 for human and rat H3, respectively.
DC9714	SCD inhibitor GSK1940029 Featured	GSK1940029 is a stearoyl CoA desaturase 1 inhibitor.
DC20282	GSK199 Featured	GSK199 is a reversible inhibitor of PAD4 (IC50 = 200 nM) that binds to the low-calcium form of the enzyme and is selective for PAD4 over PAD1-3.
DC11415	GSK2033 Featured	GSK2033 is a LXR antagonist with pIC50s of 7 and 7.4 for LXRα or LXRβ, respectively.
DC7141	Omipalisib Featured	GSK2126458 is a highly selective and potent inhibitor of PI3K with Ki of 0.019 nM/0.13 nM/0.024 nM/0.06 nM and 0.18 nM/0.3 nM for p110α/β/δ/γ, mTORC1/2 , respectively.
DC10865	GSK2193874 Featured	GSK2193874 is an orally active, potent, and selective TRPV4 antagonist with IC50 of 2 nM and 40 nM for rTRPV4 and hTRPV4.
DC10912	GSK-2200150A Featured	GSK2200150A is an antimycobacterial agent against Mycobacterium tuberculosis and Mycobacterium bovis BCG.
DC8331	GSK2256098 Featured	GSK2256098 is small molecule FAK kinase inhibitor.
DC7650	GSK2334470 Featured	GSK2334470 is a novel PDK1 inhibitor with IC50 of ~10 nM, with no activity at other close related AGC-kinases.
DC8520	GSK-25 Featured	GSK-25 maintains good selectivity against a panel of 31 kinases, as well as RSK1 and p70S6K (RSK1 IC50 of 398 nM, p70S6K IC50 of 1000nM), and a dramatically improved P450 profile (>2.2 uM at all isozymes tested).
DC8767	GSK256066 Featured	GSK256066 is a selective PDE4B(equal affinity to isoforms A-D) inhibitor with IC50 of 3.2 pM, >380,000-fold selectivity versus PDE1/2/3/5/6 and >2500-fold selectivity against PDE4B versus PDE7.
DC7852	LRRK2 inhibitor GSK2578215A Featured	GSK2578215A is a potent and highly selective LRRK2 inhibitor; exhibits IC50s of around 10 nM against both wild-type LRRK2 and the G2019S mutant.
DC7142	GSK2606414 Featured	GSK2606414 is an orally available, potent, and selective PERK inhibitor with an IC50 of 0.4 nM.
DC6315	GSK2636771 Featured	GSK2636771 is a potent, orally bioavailable, PI3Kβ-selective inhibitor, sensitive to PTEN null cell lines. Phase 1/2a.
DC12049	GSK2643943A Featured	GSK2643943A is a potent USP20 inhibitor with IC50 = 160 nM.
DC5029	PERK inhibitor GSK2656157 Featured	GSK2656157 is an ATP-competitive inhibitor of PERK enzyme activity with an IC50 of 0.9 nM. It is highly selective for PERK with IC50 values >100 nM against a panel of 300 kinases.
DC7249	ROCK inhibitor GSK269962A Featured	GSK269962A(GSK269962) is a potent ROCK inhibitor (IC50 values are 1.6 and 4 nM for recombinant human ROCK1 and ROCK2 respectively); displays greater than 30-fold selectivity for ROCK against a panel of serine/threonine kinases.
DC7853	GSK2801 Featured	GSK2801 is a very potent inhibitor of the BAZ2 family of bromodomain containing proteins.
DC10886	GSK2807 Featured	GSK-2807 (GSK 2807, GSK2807) is a potent and selective, SAM-competitive inhibitor of SMYD3 with Ki of 14 nM.
DC9719	Lp-PLA2 -IN-1(GSK2814338) Featured	GSK2814338, also known as Lp-PLA2 -IN-1, is a Lp-PLA2 inhibitor
DC7847	HIV Inhibitor GSK2838232 Featured	GSK2838232 is a novel human immune virus (HIV) maturation inhibitor being developed for the treatment of chronic HIV infection.
DC8491	GSK2879552 Featured	GSK2879552 is an orally available, irreversible, inhibitor of lysine specific demethylase 1 (LSD1), with potential antineoplastic activity.
DC9738	GSK2881078 Featured	GSK-2881078 is an orally active and nonsteroidal selective androgen receptor modulator (SARM) which act as partial AR agonists in androgenic tissues while mainly as complete AR agonists in synthetic metabolic tissues,induces AR-mediated transcriptional activation in PC3(AR)2 cells (EC50 = 3.99 nM) and the effect can be inhibited by the non-steroidal AR antagonist Bicalutamide. GSK-2881078 can be used in research of muscle weakness and cachexia associated with both chronic and acute illness.
DC22317	GSK-2894631A(HPGDS inhibitor 2) Featured	GSK-2894631A,GSK 2894631A，GSK2894631A
DC9713	GSK2981278 Featured	GSK2981278 is a highly potent and selective inverse agonist of retinoic acid receptor-related orphan receptor gamma (ROR gamma).
DC10787	GSK2982772 Featured	GSK2982772 is a potent and ATP competitive RIP1 inhibitor with an IC50 of 16 nM.
DC9721	GSK2983559 active metabolite Featured	GSK2983559 active metabolite is an active metabolite of GSK2983559. GSK2983559 active metabolite is a receptor interacting protein-2 (RIP2) kinase inhibitor extracted from patent WO/2014043446 A1, compound example 1.
DC9717	amyloid P-IN-1(GSK3039294) Featured	GSK3039294 is a Serum amyloid P component inhibitor.
DC9715	CHR5154 Featured	GSK3117391 (CHR5154) is a HDAC inhibitor.
DC26011	GSK3145095 Featured	GSK3145095 is an orally available, small-molecule inhibitor of RIPK1, with potential antineoplastic and immunomodulatory activities.

Featured products

Customized Consultation X

Your information is safe with us. * Required Fields.